Back to MW MARSHALL WACE, LLP

VKTXVKTX
14 quarters

Position history for MWMARSHALL WACE, LLP's holdings in VIKING THERAPEUTICS INC

MARSHALL WACE, LLP holds 42,767 shares of VKTX (VIKING THERAPEUTICS INC), worth $1.7M as of 2026-Q2. The position was decreased (-52.7% shares). VKTX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1.7M

Current Shares

42,767

Total Value Change

-$2M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
42,767
-52.7%
$1.7M0.0%$39.01
0
2026-Q1
New
90,360
-
$2.9M0.0%$31.93
36
2025-Q2
Exited
0
-100.0%
$00.0%$26.52
0
2025-Q1
Increased
207,873
+933.5%
$5M0.0%$25.65
43
2024-Q4
Increased
20,114
+12.6%
$809,3870.0%$39.77
28
2024-Q3
Decreased
17,858
-75.8%
$1.1M0.0%$61.63
0
2024-Q2
Decreased
73,700
-80.2%
$3.9M0.0%$53.01
0
2024-Q1
Increased
371,686
+261.4%
$30.5M0.0%$82.00
46
2023-Q4
Increased
102,855
+95.7%
$1.9M0.0%$18.61
41
2023-Q3
Decreased
52,558
-60.5%
$581,8160.0%$11.07
0
2023-Q2
Increased
133,190
+57.2%
$2.2M0.0%$15.62
37
2023-Q1
Increased
84,723
+20.5%
$1.4M0.0%$17.33
30
2022-Q4
Decreased
70,335
-94.7%
$661,1490.0%$9.40
0
2022-Q3
New
1.3M
-
$3.6M0.0%$2.75
37

Other major holders of VKTX: BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used